Výsledky vyhledávání - "Lisa D. Tremblay"

Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase

Autor: Chad Cherington, Ruben A. Mesa, Jane Olsen, Meagan S. Higgins, Roberta H. Adams, Veena Fauble, Jose F. Leis, Pierre Noel, Lisa D. Tremblay, James L. Slack, Jeffrey Betcher, John K. Camoriano, Raoul Tibes, Mary E Peterson, Ginger Gillette-Kent, Craig B. Reeder, Joseph R. Mikhael

Publikováno v: Leukemia Research. 36:1147-1151

The prognosis for patients with Philadelphia-negative myeloproliferative neoplasms (MPN) who evolve into acute myeloid leukemia (AML) or blast phase (MPN-BP) is extremely poor. Although allogeneic stem cell transplantation (allo-SCT) is considered po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84d6f29f07e83242a47115d6a5f93359
https://doi.org/10.1016/j.leukres.2012.04.021

Zobrazit plný text záznamu

Induction Therapy Followed by Allogeneic Stem Cell Transplant for MPN Blast Phase: Outcomes From Mayo Clinic in Arizona

Autor: Roberta H. Adams, Jose F. Leis, James L. Slack, Chad Cherington, Pierre Noel, John K. Camoriano, Raoul Tibes, Jane Olsen, Jeffrey Betcher, Ruben A. Mesa, Mary E Peterson, Meagan S. Higgins, Joseph R. Mikhael, Lisa D. Tremblay, Ginger Gillette-Kent, Craig B. Reeder

Publikováno v: Blood. 118:1749-1749

Abstract 1749 BACKGROUND: We have previously reported that transformation of a myeloproliferative neoplasm (MPN) to acute leukemia or blast phase (MPN-BP) is accompanied by a median survival of 2.6 months (range 0–24.2 months) (Mesa et. al. Blood 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::786cdbd368e3e4f1c8b1146e78d646b7
https://doi.org/10.1182/blood.v118.21.1749.1749

Zobrazit plný text záznamu

In-Vivo T-Cell Depletion with Rabbit Anti-Thymocyte Globulin (r-ATG) Prevents Severe Acute and Chronic Graft Versus Host Disease (GVHD) and Allows Safe Allogeneic Stem Cell Transplantation (allo-SCT) From Mismatched, Unrelated Donors

Autor: James L. Slack, Mary E Peterson, Roberta H. Adams, Lisa D. Tremblay, Pierre Noel, Meagan S. Higgins, Jose F. Leis, Joseph R. Mikhael, Craig B. Reeder, Jane J. Olson, Raoul Tibes, Ginger Gillette-Kent, Ruben A. Mesa, Jeffrey Betcher

Publikováno v: Blood. 118:1977-1977

Abstract 1977 Introduction: Transplant options are limited for adult patients (pts) who lack a fully matched related or unrelated donor. We hypothesized that in-vivo T-cell depletion with r-ATG would allow safe allo-SCT from mismatched, unrelated don

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b19717994a75c416becc6f529a9e33c1
https://doi.org/10.1182/blood.v118.21.1977.1977

Zobrazit plný text záznamu

Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML): Low Incidence of Relapse and Graft Versus Host Disease (GVHD) in Patients (pts) Transplanted without Active Leukemia Using in-Vivo T-Cell Depletion with Rabbit Anti-Thymocyte Globulin (r-ATG)

Autor: Ruben A. Mesa, Lisa D. Tremblay, Roberta H. Adams, Craig B. Reeder, Ginger Gillette-Kent, Joseph R. Mikhael, Pierre Noel, Jane Olsen, Jose F. Leis, Jeffrey Betcher, Mary E Peterson, Raoul Tibes, Meagan S. Higgins, James L. Slack

Publikováno v: Blood. 118:4527-4527

Abstract 4527 Introduction: The prognosis for pts with intermediate or high risk AML remains dismal, with relapse rates typically in the 60–80% range after treatment with chemotherapy alone. While allo-SCT can decrease the risk of relapse to 10–2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c3ee2019bc28580ba2b78276c91c2dde
https://doi.org/10.1182/blood.v118.21.4527.4527

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání